Skip to main content
. 2019 Feb 13;8(1):5. doi: 10.3390/ht8010005

Table 3.

Biochemical features of all samples analyzed.

Sample # Clinical Classification of the Disorder AAT Assay (mg/dL) Neutrophil Count Elastase Specific Activity (mU/mg) Cathepsin G Specific Activity (mU/mg) Presence of the 80 kDa Complex
1 Stable 0.57 * 1 n.d. ** n.d. ** NO
2 Stable 1.00 1 0.08 n.d. NO
3 Stable 0.32 1 n.d. n.d. NO
4 Stable 0.79 34 0.725 n.d. YES
5 Stable 0.37 30 1.06 0.14 YES
6 Stable 0.40 1 n.d. n.d. YES
7 BOS 0p 0.26 28 0.29 n.d. YES
8 BOS II 2.50 94 4.44 0.57 YES
9 BOS II 0.56 56 2.16 0.254 YES
10 BOS II 0.12 40 2.98 n.d. YES
11 BOS II 0.12 5 2.23 n.d. YES
12 BOS III 0.13 10 n.d. n.d. YES
13 BOSIII 0.13 15 1.56 n.d. YES

* Values reported are the mean of three independent determinations. Standard deviation was within 5%. ** n.d. = not detectable.